Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger M Nitsch

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Alzheimer Disease and Associated Disorders|December 14, 2004
Immunotherapy of Alzheimer diseaseRoger M Nitsch
Molecular Brain|March 30, 2019
The secreted APP ectodomain sAPPα, but not sAPPβ, protects neurons against Aβ oligomer-induced dendritic spine loss and increased tau phosphorylationChristian Tackenberg, Roger M Nitsch
Frontiers in Aging Neuroscience|January 20, 2022
Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in DementiaRuiqing Ni, Roger M Nitsch
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 16, 2008
Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapyRoger M Nitsch, Christoph Hock
Neuro-Degenerative Diseases|August 16, 2006
Clinical observations with AN-1792 using TAPIR analysesChristoph Hock, Roger M Nitsch
Neuro-Degenerative Diseases|March 23, 2016
PrefaceAbraham Fisher, Roger M Nitsch, Manfred Windisch
Acta Neuropathologica|March 19, 2016
Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathyMario Merlini, Debora Wanner, Roger M Nitsch
Plos One|September 23, 2020
Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo systemChristian Tackenberg, Luka Kulic, Roger M Nitsch
Plos One|April 13, 2011
Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's diseaseSusann Cattepoel, Michael Hanenberg, Luka Kulic, et al.
The Journal of Biological Chemistry|July 10, 2002
Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivoM Hasan Mohajeri, M Axel Wollmer, Roger M Nitsch
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Alzheimer Disease and Associated Disorders|December 14, 2004
Immunotherapy of Alzheimer diseaseRoger M Nitsch
Molecular Brain|March 30, 2019
The secreted APP ectodomain sAPPα, but not sAPPβ, protects neurons against Aβ oligomer-induced dendritic spine loss and increased tau phosphorylationChristian Tackenberg, Roger M Nitsch
Frontiers in Aging Neuroscience|January 20, 2022
Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in DementiaRuiqing Ni, Roger M Nitsch
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 16, 2008
Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapyRoger M Nitsch, Christoph Hock
Neuro-Degenerative Diseases|August 16, 2006
Clinical observations with AN-1792 using TAPIR analysesChristoph Hock, Roger M Nitsch
Neuro-Degenerative Diseases|March 23, 2016
PrefaceAbraham Fisher, Roger M Nitsch, Manfred Windisch
Acta Neuropathologica|March 19, 2016
Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathyMario Merlini, Debora Wanner, Roger M Nitsch
Plos One|September 23, 2020
Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo systemChristian Tackenberg, Luka Kulic, Roger M Nitsch
Plos One|April 13, 2011
Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's diseaseSusann Cattepoel, Michael Hanenberg, Luka Kulic, et al.
The Journal of Biological Chemistry|July 10, 2002
Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivoM Hasan Mohajeri, M Axel Wollmer, Roger M Nitsch
Pageof 18